The DOI matches its Crossref record; 62 of the 64 references it cites were found in a registry or an index.
The innate immunity protein IFITM3 modulates γ-secretase in Alzheimer’s disease
Open accessAbstract
Innate immunity is associated with Alzheimer's disease 1, but the influence of immune activation on the production of amyloid-β is unknown 2,3. Here we identify interferon-induced transmembrane protein 3 (IFITM3) as a γ-secretase modulatory protein, and establish a mechanism by which inflammation affects the generation of amyloid-β. Inflammatory cytokines induce the expression of IFITM3 in neurons and astrocytes, which binds to γ-secretase and upregulates its activity, thereby increasing the production of amyloid-β. The expression of IFITM3 is increased with ageing and in mouse models that express familial Alzheimer's disease genes. Furthermore, knockout of IFITM3 reduces γ-secretase activity and the formation of amyloid plaques in a transgenic mouse model (5xFAD) of early amyloid deposition. IFITM3 protein is upregulated in tissue samples from a subset of patients with late-onset Alzheimer's disease that exhibit higher γ-secretase activity. The amount of IFITM3 in the γ-secretase complex has a strong and positive correlation with γ-secretase activity in samples from patients with late-onset Alzheimer's disease. These findings reveal a mechanism in which γ-secretase is modulated by neuroinflammation via IFITM3 and the risk of Alzheimer's disease is thereby increased.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Activated microglia may be involved in the generation of Aβ plaque by increasing the secretion of Aβ fragments; inducing the expression of interferon-induced transmembrane protein 3 (IFITM3), a γ-secretase modulatory protein; or releasing agents such as iron, which enhances the aggregation of soluble β-amyloid.37–39”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [39]
In the citing paper
“Brain inflammation can also trigger deposition of pathological amyloid proteins via upregulation of interferon‐induced transmembrane protein 3 (IFITM3). 104”
From Senescence, brain inflammation, and oligomeric tau drive cognitive decline in Alzheimer's disease: Evidence from clinical and preclinical studies (2024) · cites this paper as [104]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
The Genotype-Tissue Expression (GTEx) pilot analysis: Multitissue gene regulation in humans
The GTEx Consortium, Ardlie, K. G., Deluca, D. S., Segrè, A. V., Sullivan, T. J., Young, T. R., Gelfand, E. T., Trowbridge, C. A., Maller, J. B., Tukiainen, T., et al. (2015) · Science · doi:10.1126/science.1262110 · Cited by 5,062
Self-citationOakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530
Self-citationTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Self-citationVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Self-citationProcessing of gene expression data generated by quantitative real-time RT-PCR.
Muller, P. Y., Janovjak, H., Miserez, A. R., & Dobbie, Z. (2002) · PubMed · Cited by 1,394
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971
Research works printed but not linked: 1
- Placanica, L. et al. Pen2 and presenilin-1 modulate the dynamic equilibrium of presenilin-1 and presenilin-2 gamma-secretase complexes. J. Biol. Chem. 284, 2967–2977 (2009). · DOI
Cited by
Sorted by citations
Items 201–300 of 386
The role of SPP / SPPL intramembrane proteases in membrane protein homeostasis
Mentrup, T., Leinung, N., Patel, M., Fluhrer, R., & Schröder, B. (2023) · FEBS Journal · doi:10.1111/febs.16941 · Cited by 11
Hakem, F. T., Fouad, Y. F., & Arafa, R. K. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266259174231006070637 · Cited by 10
Alterations of mRNAs and Non-coding RNAs Associated with Neuroinflammation in Alzheimer’s Disease
Hernández-Contreras, K. A., Martínez-Díaz, J. A., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Rojas-Durán, F., Chi-Castañeda, D., García, L. I., & Aranda-Abreu, G. E. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03908-5 · Cited by 11
Novel Development and Prospects in Pathogenesis, Diagnosis, and Therapy of Alzheimer’s Disease
Teng, Z. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230130 · Cited by 10
Imaging of Cancer γ-Secretase Activity Using an Inhibitor-Based PET Probe
Nie, P., Kalidindi, T., Nagle, V. L., Wu, X., Li, T., Liao, G. P., Frost, G., Henry, K. E., Punzalan, B., Carter, L. M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0940 · Cited by 10
Self-citationVavougios, G. D., de Erausquin, G. A., & Snyder, H. M. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.1063298 · Cited by 11
Gholami, M., Sakhaee, F., Gheinari, F. M., Sotoodehnejadnematalahi, F., Jajin, M. G., Zamani, M. S., Ahmadi, I., Anvari, E., & Fateh, A. (2023) · Journal of Immunology Research · doi:10.1155/2023/2345062 · Cited by 10
Pan, A. L., Audrain, M., Sakakibara, E., Joshi, R., Zhu, X., Wang, Q., Wang, M., Beckmann, N. D., Schadt, E. E., Gandy, S., et al. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400447 · Cited by 9
Self-citationSynergetic effect of β-asarone and cannabidiol against Aβ aggregation in vitro and in vivo
Duan, F., Ju, T., Song, C., Liu, M., Xiong, Y., Han, X., & Lu, W. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.07.028 · Cited by 9
Proteomic and Transcriptomic Landscapes of Alström and Bardet–Biedl Syndromes
Smyczyńska, U., Stańczak, M., Kuljanin, M., Włodarczyk, A., Stoczyńska-Fidelus, E., Taha, J., Pawlik, B., Borowiec, M., Mancias, J. D., Mlynarski, W. M., et al. (2022) · Genes · doi:10.3390/genes13122370 · Cited by 10
What is the role of microbial infection in Alzheimer’s disease?
Barichello, T., Giridharan, V. V., Comim, C. M., & Morales, R. (2021) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2021-0037 · Cited by 9
S-palmitoylation and sterol interactions mediate antiviral specificity of IFITM isoformsPreprint
Das, T., Yang, X., Lee, H.-Y., Garst, E. H., Valencia, E., Chandran, K., Im, W., & Hang, H. C. (2021) · Research Square · doi:10.21203/rs.3.rs-1179000/v1 · Cited by 9
Immunity gene IFITM3 variant: Relation to cognition and Alzheimer's disease pathology
Pyun, J., Park, Y. H., Hodges, A., Jang, J., Bice, P. J., Kim, S., Saykin, A. J., & Nho, K. T. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12317 · Cited by 7
Kadam, R., Gupta, M., Lazarov, O., & Prabhakar, B. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae134 · Cited by 8
Pathological Mechanisms and Molecular Imaging Advances in Alzheimer’s Disease
Liu, C., Meng, Y., Liu, R., Wang, Z., & Zhao, H. (2025) · Clinical Interventions in Aging · doi:10.2147/cia.s534015 · Cited by 8
Viruses - a major cause of amyloid deposition in the brain
Fülöp, T., Ramassamy, C., Lévesque, S., Frost, E. H., Laurent, B., Lacombe, G., Khalil, A., Larbi, A., Hirokawa, K., Desroches, M., et al. (2023) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2023.2244162 · Cited by 8
Discovery and Characterization of IFITM S-Palmitoylation
Das, T., & Hang, H. C. (2023) · Viruses · doi:10.3390/v15122329 · Cited by 8
Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
Bartolomé, F. B., Rosa, L., Valenti, P., Lopera, F. J., Hernández‐Gallego, J., Cantero, J. L., Orive, G., & Carro, E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878201 · Cited by 8
He, Y., Xue, Y., Wang, J., Huang, Y., Liu, L., Huang, Y., & Gao, Y. Q. (2023) · Genome Research · doi:10.1101/gr.277737.123 · Cited by 8
Self-citationZheng, Y., Xu, W., Suo, Z., Qu, Y., Lin, L., Zhang, E., Han, D., Wu, M., Hongyi, L. I., Zheng, H., et al. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03566-5 · Cited by 8
Calcines-Rodríguez, L., Noyes-Martel, N., Becker, J. D., Nguyen, S. K., Osabutey, M., Trojanczyk, L., Majewska, A. K., & O’Banion, M. K. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03659-1 · Cited by 8
Carvalho, D. B., Díaz‐Amarilla, P., Dapueto, R., Santi, M. D., Duarte, P., Savio, E., Engler, H., Abin‐Carriquiry, J. A., & Arredondo, F. (2023) · Journal of Molecular Neuroscience · doi:10.1007/s12031-023-02105-2 · Cited by 7
The role of the gut microbiome in the regulation of astrocytes in Alzheimer's disease
Chandra, S., & Vassar, R. J. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00425 · Cited by 7
Self-citationMolecular characterization, expression and functional analysis of yak IFITM3 gene
Wang, H., Wang, L., Li, J., Fu, F., Zheng, Y., & Zhang, L. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.06.057 · Cited by 7
Xiang, X., Feng, Z., Wang, L., Wang, D., Li, T., Yang, J., Wang, S., Xiao, F., & Zhang, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114628 · Cited by 6
Self-citationHuang, Q., Lv, Y. M., Ye, X. W., Xia, X., Chen, Y., Wang, X., Tong, F., Yang, W., Bozorov, K. A., Shevtsov, M. A., et al. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114896 · Cited by 6
Unveiling the role of KLF9‐mediated IFITM3 regulation in amyloidogenesis
Feng, Y., Zhou, Q., Hu, B., Wang, S., Chen, L., Cai, W., Zhu, Q., Qin, X. R., Zhou, W., Wu, Y., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202401584rr · Cited by 7
Glucose Metabolism, Lactate, Lactylation and Alzheimer’s Disease
Hai, S., Hou, Y., Zhang, M., Gao, X., Yang, T., Shang, X., & Sun, X. (2025) · Aging and Disease · doi:10.14336/ad.2025.0338 · Cited by 9
Down-regulation of cyclin D2 in amyloid β toxicity, inflammation, and Alzheimer’s disease
Czapski, G. A., Cieślik, M., Białopiotrowicz, E., Lukiw, W. J., & Strosznajder, J. B. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259740 · Cited by 6
Li, N., Ma, R., Zhang, E., Feng, G., Fang, D.-Y., Zhang, J., Zhang, Y.-N., Gao, Y., Hou, L., & Jin, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1182005 · Cited by 6
Xie, Q., Liao, X., Huang, B., Wang, L., Liao, G., Luo, C., Wen, S., Fang, S., Luo, H., & Shu, Y. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2246599 · Cited by 5
The association of microbial infection and adaptive immune cell activation in Alzheimer’s disease
Clement, M. (2023) · Discovery Immunology · doi:10.1093/discim/kyad015 · Cited by 6
Jacques, M., Landen, S., Sharples, A. P., GARNHAM, A. P., Schittenhelm, R. B., Stele, J., Heikkinen, A., Sillanpää, E., Ollikainen, M., Broatch, J. R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.14.603458 · Cited by 6
Potential molecular mechanisms of tobacco smoke exposure in Alzheimer’s disease
Xie, Y., Yang, M., Wang, H., Chen, Y., Shi, X., Tang, H., & Sun, Q. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149394 · Cited by 6
Wang, M., Hu, Z., Xiang, Y., Zeng, X., Fei, Z.-C., Chen, J., Li, X., Zhu, Y.-P., Wang, J., Wang, Y., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100131 · Cited by 5
Self-citationZare, M.-S., Abedpoor, N., Hajibabaie, F., & Walker, A. K. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106944 · Cited by 6
Multiple Sclerosis Biomarker Candidates Revealed by Cell-Type-Specific Interactome Analysis
Yurduseven, K., Babal, Y. K., Çelik, E., Kerman, B. E., & Kurnaz, I. A. (2022) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2022.0023 · Cited by 5
The role of Aβ in Alzheimer's Disease as an Evolutionary Outcome of Optimized Innate Immune Defense
Tatar, M. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.68 · Cited by 6
Vavougios, G. D., Mavridis, T., Doskas, T. K., Papaggeli, O., Foka, P., & Hadjigeorgiou, G. M. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050277 · Cited by 5
Xie, Z., Li, L., Hou, W., Fan, Z., Zeng, L., He, L., Ji, Y., Zhang, J., Wang, F. J., Xing, Z., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06112-2 · Cited by 6
Buchrieser, J., & Schwartz, O. (2021) · Comptes Rendus Biologies · doi:10.5802/crbiol.54 · Cited by 5
Svedružić, Ž. M., Jengić, V. Š., & Ostojić, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031835 · Cited by 5
Arnaud, L., Benech, P. D., Greetham, L., Stephan, D., Jimenez, A., Jullien, N. D., García‐González, L., Tsvetkov, P. O., Devred, F., Sancho-Martinez, I., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.16.440108 · Cited by 5
Pathogenesis of Alzheimer’s disease: Involvement of the Choroid PlexusPreprint
Čarná, M. E., Onyango, I. G., Katina, S., Holub, D., Nezvedová, M., Jha, D., Nedelská, Z., Lacovich, V., Vyvere, T. V., Houbrechts, R., et al. (2021) · medRxiv · doi:10.1101/2021.07.29.21260696 · Cited by 5
Self-citationEtebar, F., White, A. R., & Quek, H. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1770518 · Cited by 4
Yang, J., Tsourdinis, G. E., Holas, C., Maienschein‐Cline, M., Lalonde, R., & Fukuchi, K.-I. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1694824 · Cited by 4
γ-Secretase fanning the fire of innate immunity
Liu, C., Nikain, C., & Li, Y.-M. (2023) · Biochemical Society Transactions · doi:10.1042/bst20221445 · Cited by 4
Self-citationAdvances in clinical neurorestorative treatments in brain trauma
Zhou, Q., Shen, W., & Wen, L. (2025) · Journal of Neurorestoratology · doi:10.1016/j.jnrt.2025.100191 · Cited by 4
Neuroimmune regulation of IFITM3 via γ-secretase in astrocytes during cerebral ischemia-reperfusion
Ni, X.-Q., Pan, Y., Liu, X., Zhu, Y., Yao, X., Mo, Y., Dai, Q., & Wang, J. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167733 · Cited by 4
Self-citationYan, X., Wang, E., Zhao, M. L., Ma, G., Xu, X.-X., Zhao, J.-B., Li, X., Zeng, J., & Ma, X. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.03.019 · Cited by 5
Ullah, I., Mengersen, K. L., Pettitt, A. N., & Liquet, B. (2025) · Statistics in Medicine · doi:10.1002/sim.70110 · Cited by 4
The manipulator behind “Scissors”: γ -secretase and its modulators in Alzheimer’s disease
Ning, G., Fan, X., Du, J., wenxue, Z., Sijia, W., Meinei, C., Xiaolong, D., & Yiming, Q. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1637671 · Cited by 5
MARCH8-mediated ubiquitination regulates expression of the antiviral protein IFITM3
Wei, L., Zhao, F., Liu, X., Mei, S., Huang, Y., Xie, Y., Hu, Y., Wang, L., Wang, L., Gao, Z., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110879 · Cited by 4
Self-citationWon, S., Kim, Y., & Jeong, B. (2021) · Medicina · doi:10.3390/medicina58010055 · Cited by 4
Self-citationSim, K.-Y., Byeon, Y., Bae, S.-E., Yang, T., Lee, C., & Park, S. (2023) · Scientific Reports · doi:10.1038/s41598-023-34105-y · Cited by 4
Li, Y., Zhang, J., Liu, X., Zhang, X., & Shi, G. (2024) · Lupus · doi:10.1177/09612033241304454 · Cited by 4
Self-citationNeurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer’s Disease
Doskas, T. K., Vavougios, G. D., Kormas, C., Kokkotis, C., Tsiptsios, D., Spiliopoulos, K. C., Tsiakiri, A., Christidi, F., Aravidou, T., Dekavallas, L., et al. (2025) · Brain Sciences · doi:10.3390/brainsci15060564 · Cited by 7
Identification of potential modulators of IFITM3 by in-silico modeling and virtual screening
Tiwari, V. R., & Viswanath, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-20259-8 · Cited by 4
Wang, Z., Sun, X., Zhao, Y., Ga, L., Li, Q., Li, Q., Wang, X., & Yang, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.949757 · Cited by 4
Multifactorial glial responses and their contributions to Alzheimer's disease continuum
Hijioka, M., Manabe, T., & Saito, T. (2023) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12745 · Cited by 4
Yang, J., Li, Y., Bhalla, A., Maienschein‐Cline, M., & Fukuchi, K.-I. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288497 · Cited by 5
Self-citationDr Jekyll and Mr Hyde: From Two Branches of Immune Response to Three Types of Interferon ResponsePreprint
Brown, B. (2023) · Qeios · doi:10.32388/pbxuf5 · Cited by 4
Abnormal behaviors and glial responses in an animal model of tau pathology
Liu, Y., Sobue, A., Sahara, N., Isobe, M., Tanaka, R., Zhu, Y., Zhu, W., Matsuzaki, T., Yamanaka, K., Yamada, K., et al. (2025) · Molecular Brain · doi:10.1186/s13041-025-01252-4 · Cited by 3
Neuharth, J., Hernandez, K. A., Bernholtz, J., Edwards, H., & Stewart, A. (2025) · Biology of Sex Differences · doi:10.1186/s13293-025-00788-3 · Cited by 3
Liu, X.-W., Zhang, S., Xu, H.-W., Lu, J.-H., Chang, S.-J., Huang, S.-S., & Wang, S. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.150917 · Cited by 3
Constructing Neuroinflammation‐On‐A‐Chip for Traditional Chinese Medicine Extracts Evaluation
Wang, X., Lin, X., Zhi, Y., Shang, L., Luo, Y., & Wang, Y. F. (2026) · Smart Medicine · doi:10.1002/smmd.70032 · Cited by 3
Type-1 interferons associated with microglial-mediated neuroinflammation in Alzheimer’s disease
Shippy, D. C., Sande, M. L., & Ulland, T. K. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03828-w · Cited by 3
Targeting inflammaging in Alzheimer’s disease: molecular pathways and emerging pharmacotherapies
Alotaibi, M. O., Al‐kuraishy, H. M., Fahad, E. H., Abdelaziz, A. M., & Batiha, G. E. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02281-8 · Cited by 3
Liu, Y., Ye, Y., Fan, M., Cheng, Y., Sun, S., & Qiu, Z. (2026) · Neuron · doi:10.1016/j.neuron.2026.05.015 · Cited by 2
STING-dependent peripheral inflammaging drives neurodegeneration via extracellular vesicles
Öberg, M., Myers, C., Saffarzadeh, N., Marić, I., Murillo-Léon, M., Strömberg, A., Fabriková, D., Fabrik, I., Rivas-Galvez, L., Deshmukh, M. V., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117640 · Cited by 3
Decoding Alzheimer's Disease With Depression: Molecular Insights and Therapeutic Target
Li, Z., Guo, H., Ge, Y., Li, X., Dong, F., & Zhang, F. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70454 · Cited by 4
APOE ε3/ε4 and APOE ε4/ε4 genotypes drive unique gene signatures in the cortex of young micePreprint
Foley, K. E., Garceau, D. T., Kotredes, K. P., Carter, G. W., Sasner, M., & Howell, G. R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.28.359422 · Cited by 3
Rodriguez, L. C., Noyes-Martel, N., Becker, J. D., Majewska, A. K., & O’Banion, M. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646050 · Cited by 3
IFITM2 Modulates Endocytosis Maintaining Neural Stem Cells in Developing Neocortex
Lv, Y., Zou, W., Li, L., Zhang, S., Liang, J., Pu, J., & Jiao, J. (2025) · Advanced Science · doi:10.1002/advs.202501593 · Cited by 2
Cheng, Y., Santucci, K., Gao, Y., Takenaka, K., Lindner, G., Xu, S.-M., & Janitz, M. (2026) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02469-7 · Cited by 3
IFITM3-mediated neuroinflammation in epilepsy regulated by the let-7g-5p/STAT2 axis
Liu, J., Sheng, D., Li, X., Yazgulyyeva, B., Wang, Y., Xiao, B., & Liu, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-44357-z · Cited by 2
Huang, S., Tu, C., Fei, Y., Wang, M., Deng, M., & Xia, J. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c17039 · Cited by 2
Self-citationHu, D., Li, T., He, J., Jiang, Y., Wang, Y., & Sun, J. (2026) · Advanced Science · doi:10.1002/advs.75342 · Cited by 2
Self-citationBufi, A. A., Papait, A., Ponsaerts, P., Silini, A. R., & Parolini, O. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00554-4 · Cited by 3
TNF-α induces type I IFN signalling to suppress neurogenesis and recruit T cells
Nissen, T. A. D., Baig, A., Farmand, S., Rock, D. T., Shibu, S., Lee, H., O'Neill, L. A., Houghton, V., John, S., Klavinskis, L. S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-74104-x · Cited by 2
Contreras, W., Bazán, J. F., & Mentrup, T. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04823-7 · Cited by 2
Bai, H., Zeng, H.-M., Zhang, Q., Hu, Y.-Z., & Deng, F. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i6.1063 · Cited by 2
Stillman, J. M., Kiniwa, T., & Schafer, D. P. (2024) · Immunological Reviews · doi:10.1111/imr.13420 · Cited by 1
Alzheimer’s Disease from Modeling to Mechanism Research
Sun, X., & Zhang, W. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69188-1_7 · Cited by 2
Multichannel dual protein sensing using amphiphilic supramolecular assemblies
Gao, J., Prachyathipsakul, T., & Thayumanavan, S. (2021) · Chemical Communications · doi:10.1039/d1cc05407d · Cited by 2
Organs-on-a-Chip in Preclinical Studies
Parvatam, S., & Chavali, P. L. (2022) · Springer eBooks · doi:10.1007/978-981-19-1379-2_23 · Cited by 2
Qiu-Yue, X., Tian-Yuan, Y., Wang, X., Qi, D., & Xiao-Rui, C. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221201143323 · Cited by 2
Li, Z., Ip, B. Y. M., Mok, V., & Ko, H. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.313042 · Cited by 2
Boreland, A. J., Stillitano, A. C., Lin, H.-C., Abbo, Y., Hart, R. P., Jiang, P., Pang, Z. P., & Rabson, A. B. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.25.563950 · Cited by 2
CSF interferon-β: A key player in Alzheimer’s disease pathogenesis and cognitive impairmentPreprint
Shen, Y., Wang, Q., Yuan, S., Wang, C., Huang, D., Zhang, M., Zhan, Y., Gao, F., Shi, J., & Levey, A. I. (2023) · Research Square · doi:10.21203/rs.3.rs-3591564/v1 · Cited by 2
Duff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N. E., Runz, H., Laban, R., Veleva, E., Whelan, C. D., et al. (2024) · medRxiv · doi:10.1101/2024.02.02.24302132 · Cited by 2
Mitigating neuroinflammation in cognitive areas: exploring the impact of HMG-CoA reductase inhibitor
Catalão, C. H. R., da Costa, L. H. A., dos Santos, J. R., Alberici, L. C., Falconi‐Sobrinho, L. L., Coimbra, N. C., Dominguini, D., Dal‐Pizzol, F., Barichello, T., & Rocha, M. J. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240217 · Cited by 1
The dissipation theory of aging: a quantitative analysis using a cellular aging map
Khodaee, F., Zandie, R., Leger, L.-A., Xia, Y., Thadawasin, P., & Edelman, E. R. (2025) · npj Aging · doi:10.1038/s41514-025-00277-2 · Cited by 1
Zhang, T., Ruan, J., Liu, Z., Yu, Y., Lü, Y., Zhang, X., Hou, C., Liu, X., Yuan, Y., & Han, X. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.106094 · Cited by 2
Avila‐Gutierrez, K., Sauvage, M.-A. C.-D., Depret, N., Oudart, M., Thompson, R., Alvear‐Perez, R., Poulot-Becq-Giraudon, Y., Kozlowski, E., Monnet, H., Mailly, P., et al. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107528 · Cited by 1
S-acylation and neuroinflammation: the therapeutic potential of zDHHC and deacylase modulation
Duarte, T. A., Ng, C. P., Salvador, J. A. R., Pipitò, L., Greaves, J., & Moreira, V. M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.118429 · Cited by 1
Antimicrobial Peptides as Cross-Seeding Modulators at the Neurodegenerative–Infectious Interface
Zhang, Y., Tang, Y., Wang, L., & Zheng, J. (2026) · Research · doi:10.34133/research.1149 · Cited by 1
Analysis of the dual role of amyloid-beta in Alzheimer’s disease through multi-omics integration
Guo, J., Lu, X., Qiu, L., Xue, W., Fu, H., Wang, K., & Wang, Y. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00872 · Cited by 2
Antequera, D., Carrero, L., Romualdi, D., Buetas, E., García‐Consuegra, I., Cantero, J. L., Mira, A., Municio, C., & Carro, E. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119112 · Cited by 1
Rethinking Alzheimer’s: novel miRNAs illuminate a disease beyond the brain
Novotný, J., Čarná, M., Dammer, E., Mao, Z., & Stokin, G. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03487-6 · Cited by 1
Metadata
- Authors
- Hur, J.-Y., Frost, G. R., Wu, X., Crump, C., Pan, S. J., Wong, E., Barros, M., Li, T., Nie, P., Zhai, Y., Wang, J. C., TCW, J., Guo, L., McKenzie, A., Ming, C., Zhou, X., Wang, M., Sagi, Y., Renton, A. E., Esposito, B. T., Kim, Y., Sadleir, K. R., Trinh, I., Rissman, R. A., Vassar, R., Zhang, B., Johnson, D. S., Masliah, E., Greengard, P., Goate, A., & Li, Y.-M.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- Icahn School of Medicine at Mount Sinai (US)
- Rockefeller University (US)
- Northwestern University (US)
- University of California San Diego (US)
- Pfizer (United States) (US)
- Corresponding author
- Li, Yue-Ming
- ORCID
- Hur, Ji-Yeun
- Frost, Georgia R.
- Wong, Eitan
- Barros, Marilia
- Li, Thomas
- Zhai, Yujia
- TCW, Julia
- Guo, Lei
- McKenzie, Andrew
- Ming, Chen
- Zhou, Xianxiao
- Wang, Minghui
- Sagi, Yotam
- Renton, Alan E.
- Kim, Yong
- Sadleir, Katherine R.
- Trinh, Ivy
- Rissman, Robert A.
- Vassar, Robert
- Zhang, Bin
- Johnson, Douglas S.
- Masliah, Eliezer
- Greengard, Paul
- Goate, Alison
- Li, Yue-Ming
- Venue
- Nature
- Published
- 2020-09-02
- Volume
- 586
- Issue
- 7831
- Pages
- 735-740
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7919141
- OpenAlex
- W3082942379
- Cited by
- 382
- References
- 64
- Citations by year
- 2026: 53 · 2025: 51 · 2024: 53 · 2023: 68 · 2022: 77 · 2021: 65 · 2020: 15
- FWCI
- 34.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (1s10od018522-01, 1s10od026880-01)
- National Institute on Aging (R01AG057907, R01AG026660, U01AG046170, R01AG018440, R01AG006170, RF1AG057440, K01AG062683, RF1AG057593, R01AG061350, P30AG062429)
- National Cancer Institute (P30CA008748)
- National Institute of Neurological Disorders and Stroke (R01NS096275)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- IFITM3, gamma-secretase, Alzheimer's disease, amyloid-beta, innate immunity, neuroinflammation, inflammatory cytokines, presenilin, amyloid plaques, 5xFAD mice, late-onset Alzheimer's disease, aging, familial Alzheimer's disease
- MeSH terms
- Aged, 80 and over, Aging, Alzheimer Disease, Animals, Astrocytes, Disease Models, Animal, Female, Humans, Immunity, Innate, Inflammation, Male, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Risk, Up-Regulation, Amyloid beta-Protein Precursor, RNA-Binding Proteins, Age of Onset, Catalytic Domain, Mice, Presenilin-1, Amyloid Precursor Protein Secretases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
